{"nct_id":"NCT01931566","title":"Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset","status":"TERMINATED","status_verified_date":"2019-08","start_date":"2013-08-01","start_date_type":"ACTUAL","primary_completion_date":"2018-07-24","primary_completion_date_type":"ACTUAL","completion_date":"2018-09-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}